on OXURION (EBR:OXUR)
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
Oxurion NV, a biopharmaceutical company based in Leuven, Belgium, has disclosed the receipt of a transparency notification from Atlas Special Opportunities, LLC. According to Belgian regulations, the notification was received on January 16, 2025, indicating that as of January 13, 2025, Atlas held 812,202 shares. This acquisition increased Atlas's stake to 22.33% of Oxurion's outstanding shares, surpassing the 20% threshold defined by law.
The notification underscores Atlas's significant investment interest in Oxurion as the company continues to focus on developing advanced ophthalmic therapies for retinal diseases. Oxurion is listed on Euronext Brussels under the symbol OXUR.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OXURION news